Frontiers of COVID-19 : Scientific and Clinical Aspects of the Novel Coronavirus 2019 /
This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynami...
| Corporate Author: | |
|---|---|
| Other Authors: | , , , , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2022.
|
| Edition: | 1st ed. 2022. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus
- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission
- Chapter 02: Humoral immune response in SARS-CoV-2 infection and its therapeutic relevance
- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system
- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2
- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level
- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design
- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies
- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2
- Chapter 09: Emergence of COVID-19 variants and its global impact
- Section II. Clinical Observations
- Chapter 10: Psychological Impacts of the COVID-19 Pandemic
- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications
- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19
- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic
- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines
- Chapter 15: Post COVID-19 conditions-the new challenge to mankind
- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials
- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours
- Chapter 18: Neurological Complications of COVID-19
- Chapter 19: The Impact of Covid-19 on Surgical Disease
- Section III. Interventions and Treatments
- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective
- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19
- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19
- Section IV. Current Trends and Future Directions
- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy
- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges
- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms
- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination
- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !?
- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021
- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic
- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19
- Chapter 31. The road ahead.